Who owns Latigo Biotherapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of LTGO from SEC Form 13F filings across 58 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 58 institutions disclosed 41.8M shares of Latigo Biotherapeutics, Inc. worth $697.3M — about 110.3% of shares outstanding; the largest disclosed holder is 5AM Venture Management, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
58
13F holders
$697.3M
value, 2026 filers
110.3%
of shares outstanding (41.8M sh)
58
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of LTGO's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | 5AM Venture Management, LLCNEW | 7.3M | $122.3M | 41.2% | 19.4% | new |
| 2 | RA CAPITAL MANAGEMENT, L.P.NEW | 5.3M | $88.6M | 0.9% | 14% | new |
| 3 | Deep Track Capital, LPNEW | 4.4M | $73.6M | 1.2% | 11.7% | new |
| 4 | Blue Owl Capital Holdings LPNEW | 3.6M | $60.1M | 11.0% | 9.5% | new |
| 5 | Foresite Capital Management V, LLCNEW | 3.6M | $59.5M | 20.6% | 9.4% | new |
| 6 | FMR LLCNEW | 2.9M | $48.1M | 0.0% | 7.6% | new |
| 7 | Foresite Capital Management VI LLCNEW | 2.2M | $36.8M | 6.5% | 5.8% | new |
| 8 | Cormorant Asset Management, LPNEW | 1.8M | $30.3M | 2.0% | 4.8% | new |
| 9 | ORBIMED ADVISORS LLCNEW | 1.7M | $28.0M | 0.5% | 4.4% | new |
| 10 | Aberdeen Group plcNEW | 935,718 | $15.6M | 0.0% | 2.5% | new |
| 11 | VANGUARD CAPITAL MANAGEMENT LLCNEW | 865,977 | $14.5M | 0.0% | 2.3% | new |
| 12 | FARALLON CAPITAL MANAGEMENT, L.L.C.NEW | 850,000 | $14.2M | 0.1% | 2.2% | new |
| 13 | PRICE T ROWE ASSOCIATES INC /MD/NEW | 811,784 | $13.6M | 0.0% | 2.1% | new |
| 14 | RTW INVESTMENTS, LPNEW | 700,000 | $11.7M | 0.1% | 1.8% | new |
| 15 | SanofiNEW | 672,778 | $11.2M | 1.8% | 1.8% | new |
| 16 | Rock Springs Capital Management LPNEW | 654,497 | $10.9M | 0.6% | 1.7% | new |
| 17 | Balyasny Asset Management L.P.NEW | 336,450 | $5.6M | 0.0% | 0.9% | new |
| 18 | Saturn V Capital Management LPNEW | 300,355 | $5.0M | 0.7% | 0.8% | new |
| 19 | UBS Group AGNEW | 293,297 | $4.9M | 0.0% | 0.8% | new |
| 20 | BlackRock, Inc.NEW | 292,086 | $4.9M | 0.0% | 0.8% | new |
| 21 | Affinity Asset Advisors, LLCNEW | 250,000 | $4.2M | 0.2% | 0.7% | new |
| 22 | GEODE CAPITAL MANAGEMENT, LLCNEW | 220,175 | $3.7M | 0.0% | 0.6% | new |
| 23 | SPHERA FUNDS MANAGEMENT LTD.NEW | 192,120 | $3.2M | 0.5% | 0.5% | new |
| 24 | MARSHALL WACE, LLPNEW | 184,260 | $3.1M | 0.0% | 0.5% | new |
| 25 | Eversept Partners, LPNEW | 172,999 | $2.9M | 0.2% | 0.5% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.